Let's talk medical research

Increasing racial diversity in clinical research is a hot topic for industry leaders and patient advocates alike. The COVID-19 pandemic has brought a renewed focus on clinical trials, which has also sparked a conversation about not just the abstract idea of increasing racial diversity in research, but also what actionable steps toward inclusion must be taken. We take a look at how sponsors and ...

The annual Patients as Partners conference, now in its eighth year, has always been one of our favorite meetings to attend because of the care the organizers give to ensure all stakeholders, and especially patients, are represented on the agenda. Antidote’s Head of Partnerships and Patient Advocacy, Lindsey Wahlstrom-Edwards, attended this year’s virtual conference and shared her key takeaways. 

Clinical trial patient recruitment can be difficult for sponsors to get right, but having a mix of strategies in your pocket can help. With limited budgets, you may not feel like you have the space for much trial and error. Carefully reviewing your options to figure out what's best for your specific needs can help you find the right options and avoid issues down the line.

When it comes to living with chronic obstructive pulmonary disease (COPD), you don’t have to feel alone. More than 16 million Americans have COPD, and many more people are living with it undiagnosed. There are a variety of COPD resources and support networks out there, all with an array of benefits. We explore the importance of joining a COPD support group and share easy-to-access resources for ...

Healthcare equity for ethnic and racial minorities has been front and center in the media as of late. The COVID-19 pandemic illuminates some of the glaring issues that our healthcare system faces when it comes to the treatment of minority populations. 

Clinical trials are research studies that test if a new therapy is safe and effective for patients. Therapies that make it through the rigorous approval process are tested on tens of thousands of people, and it’s important that the treatment is tested on the populations who will actually use it. Women, however, have been underrepresented in these trials. We look at why women have historically ...

Jessica Thomas was driving one day when she realized she was having problems with her vision. Over the next couple of weeks, she began experiencing some unexplained numbness, tingling, and cognitive issues. “I had trouble coming up with words, which was super frustrating, as I was in graduate school at the time,” says Jessica. Within a couple of months from the onset of that very first symptom, ...

A lot can go wrong in clinical trial patient recruitment, leading to delays for up to 80% of all clinical trials. From underperforming sites to unresponsive patients, there are solutions to the most common patient recruitment challenges that can help accelerate your trial and ultimately beat your deadlines. Try these approaches if recruitment problems are putting the success of your trial at risk.

The world is focused on getting back to some semblance of normal. The promise of clinical trials to find treatments and vaccines for COVID-19 is at the forefront of everyone’s minds, and has given the public an appetite to learn more about the clinical trials process. There is a lot of information out there, and it can be difficult to cull through it all. Below is a brief guide to COVID-19 trials ...

Many factors, such as age, biological sex, disabilities, chronic comorbidities, geographical location, gender identity, race, and ethnic background, can influence how individuals react to certain drugs, medical devices, and treatment plans.